1. Home
  2. PEBK vs ACB Comparison

PEBK vs ACB Comparison

Compare PEBK & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp of North Carolina Inc.

PEBK

Peoples Bancorp of North Carolina Inc.

SELL

Current Price

$41.09

Market Cap

230.7M

Sector

Finance

ML Signal

SELL

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

SELL

Current Price

$4.16

Market Cap

232.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PEBK
ACB
Founded
1912
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.7M
232.3M
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
PEBK
ACB
Price
$41.09
$4.16
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.81
AVG Volume (30 Days)
64.4K
★ 1.8M
Earning Date
10-19-2026
11-05-2026
Dividend Yield
★ 2.03%
N/A
EPS Growth
★ 21.48
N/A
EPS
★ 2.81
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.78
P/E Ratio
$14.78
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.50
$2.56
52 Week High
$45.78
$6.36

Technical Indicators

Market Signals
Indicator
PEBK
ACB
Relative Strength Index (RSI) 37.29 38.74
Support Level $38.84 $3.78
Resistance Level $42.74 $4.67
Average True Range (ATR) 1.55 0.20
MACD -0.23 -0.11
Stochastic Oscillator 9.93 0.88

Price Performance

Historical Comparison
PEBK
ACB

About PEBK Peoples Bancorp of North Carolina Inc.

Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.

Share on Social Networks: